• Arima, K., Uéda, K., Sunohara, N., Arakawa, K., Hirai, S., Nakamura, M., Tonozuka-Uehara, H. and Kawai, M. (1998) NACP/α-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy. Acta Neuropathol. (Berl.), 96, 439444.
  • Campbell, B.C.V., McLean, C.A., Culvenor, J.G., Gai, W.P., Blumbergs, P.C., Jäkälä, P., Beyreuther, K., Masters, C.L. and Li, Q.-X. (2001) The solubility of α-synuclein in multiple system atrophy differs from that of dementia with Lewy bodies and Parkinson's disease. J. Neurochem., 76, 8796.
  • Dickson, D.W. et al. (1999) Widespread alterations of α-synuclein in multiple system atrophy. Am. J. Pathol., 155, 12411251.
  • Duda, J.E. et al. (2000) Immunohistochemical and biochemical studies demonstrate a distinct profile of α-synuclein permutations in multiple system atrophy. J. Neuropathol. Exp. Neurol., 59, 830841.
  • Fujiwara, H., Hasegawa, M., Dohmae, N., Kawashima, A., Masliah, E., Goldberg, M.S., Shen, J., Takio, K. and Iwatsubo, T. (2002) α-Synuclein is phosphorylated in synucleinopathy lesions. Nature Cell Biol., 4, 160164.
  • Fuss, B., Mallon, B., Phan, T., Ohlemeyer, C., Kirchhoff, F., Nishiyama, A. and Macklin, W.B. (2000) Purification and analysis of in vivo-differentiated oligodendrocytes expressing the green fluorescent protein. Dev. Biol., 218, 259274.
  • Gai, W.P., Power, J.H.T., Blumbergs, P.C., Culvenor, J.G. and Jensen, P.H. (1999) α-Synuclein immunoisolation of glial inclusions from multiple system atrophy brain tissue reveals multiprotein components. J. Neurochem., 73, 20932100.
  • Giasson, B.I., Duda, J.E., Murray, I.V.J., Chen, Q., Souza, J.M., Hurtig, H.I., Ischiropoulos, H., Trojanowski, J.Q. and Lee, V.M.-Y. (2000) Oxidative damage linked to neurodegeneration by selective α-synuclein nitration in synucleinopathy lesions. Science, 290, 985989.
  • Gilman, S. et al. (1999) Consensus statement on the diagnosis of multiple system atrophy. J. Neurol. Sci., 163, 9498.
  • Hanna, P.A., Jankovic, J. and Kirkpatrick, J.B. (1999) Multiple system atrophy: the putative causative role of environmental toxins. Arch. Neurol., 56, 9094.
  • Hogan, B., Constantini, F. and Lacy, E. (1995) Manipulating the Mouse Embryo: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Plainview, NY, pp. 89204.
  • Iwai, A., Masliah, E., Yoshimoto, M., Ge, N., Flanagan, L., Rohan de Silva, H.A., Kittel, A. and Saitoh, T. (1995) The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron, 14, 467475.
  • Kahle, P.J. et al. (2000) Subcellular localization of wild-type and Parkinson's disease-associated mutant α-synuclein in human and transgenic mouse brain. J. Neurosci., 20, 63656373.
  • Kahle, P.J. et al. (2001) Selective insolubility of α-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model. Am. J. Pathol., 159, 22152225.
  • Lantos, P.L. (1998) The definition of multiple system atrophy: a review of recent developments. J. Neuropathol. Exp. Neurol., 57, 10991111.
  • Mallon, B.S., Shick, H.E., Kidd, G.J. and Macklin, W.B. (2002) Proteolipid promoter activity distinguishes two populations of NG2-positive cells throughout neonatal cortical development. J. Neurosci., 22, 876885.
  • Okochi, M., Walter, J., Koyama, A., Nakajo, S., Baba, M., Iwatsubo, T., Meijer, L., Kahle, P.J. and Haass, C. (2000) Constitutive phosphorylation of the Parkinson's disease associated α-synuclein. J. Biol. Chem., 275, 390397.
  • Ozawa, T., Okuizumi, K., Ikeuchi, T., Wakabayashi, K., Takahashi, H. and Tsuji, S. (2001) Analysis of the expression level of α-synuclein mRNA using postmortem brain samples from pathologically confirmed cases of multiple system atrophy. Acta Neuropathol. (Berl.), 102, 188190.
  • Pronin, A.N., Morris, A.J., Surguchov, A. and Benovic, J.L. (2000) Synucleins are a novel class of substrates for G protein-coupled receptor kinases. J. Biol. Chem., 275, 2651526522.
  • Richter-Landsberg, C., Gorath, M., Trojanowski, J.Q. and Lee, V.M.-Y. (2000) α-Synuclein is developmentally expressed in cultured rat brain oligodendrocytes. J. Neurosci. Res., 62, 914.
  • Solano, S.M., Miller, D.W., Augood, S.J., Young, A.B. and Penney, J.B., Jr (2000) Expression of α-synuclein, parkin, and ubiquitin carboxy-terminal hydrolase L1 mRNA in human brain: genes associated with familial Parkinson's disease. Ann. Neurol., 47, 201210.
  • Spillantini, M.G., Crowther, R.A., Jakes, R., Cairns, N.J., Lantos, P.L. and Goedert, M. (1998) Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci. Lett., 251, 205208.
  • Tanji, K., Imaizumi, T., Yoshida, H., Mori, F., Yoshimoto, M., Satoh, K. and Wakabayashi, K. (2001) Expression of α-synuclein in a human glioma cell line and its up-regulation by interleukin-1β. Neuroreport, 12, 19091912.
  • Trenkwalder, C., Schwarz, J., Gebhard, J., Ruland, D., Trenkwalder, P., Hense, H.-W. and Oertel, W.H. (1995) Starnberg trial on epidemiology of Parkinsonism and hypertension in the elderly. Prevalence of Parkinson's disease and related disorders assessed by a door-to-door survey of inhabitants older than 65 years. Arch. Neurol., 52, 10171022.
  • Tu, P. et al. (1998) Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α-synuclein. Ann. Neurol., 44, 415422.